USANA Health Sciences (NYSE:USNA) Price Target Raised to $38.00

USANA Health Sciences (NYSE:USNA) had its target price upped by DA Davidson from $35.00 to $38.00 in a report released on Thursday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

Separately, StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 28th.

USANA Health Sciences Stock Performance

Shares of USNA stock opened at $36.17 on Thursday. The firm has a market cap of $689.40 million, a P/E ratio of 12.78, a P/E/G ratio of 1.25 and a beta of 0.89. The business’s 50 day moving average price is $37.86 and its 200-day moving average price is $39.55. USANA Health Sciences has a fifty-two week low of $31.44 and a fifty-two week high of $52.75.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $200.22 million for the quarter, compared to analysts’ expectations of $208.45 million. During the same quarter in the previous year, the company earned $0.59 earnings per share. As a group, equities analysts predict that USANA Health Sciences will post 2.45 EPS for the current year.

Insider Buying and Selling at USANA Health Sciences

In related news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of USNA. Exchange Traded Concepts LLC raised its position in USANA Health Sciences by 4.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after purchasing an additional 322 shares in the last quarter. Martingale Asset Management L P increased its position in USANA Health Sciences by 2.1% during the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock valued at $634,000 after buying an additional 340 shares in the last quarter. KBC Group NV increased its stake in USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares in the last quarter. Safe Harbor Fiduciary LLC purchased a new position in shares of USANA Health Sciences in the third quarter worth about $30,000. Finally, Public Sector Pension Investment Board grew its position in USANA Health Sciences by 5.4% during the 2nd quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company’s stock worth $1,098,000 after purchasing an additional 1,242 shares during the period. Hedge funds and other institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.